KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
This report outlines the developments taking place in China's pharmaceutical sector and how these may affect both multinationals and local industry players over the coming five years.
Related links
RSS feeds
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Sector Studies - These studies feature the industry insights and latest developments of specific sectors in China.